REVIEWS |
|
Kurnikova I.A., Chekalina M.S., Ualikhanova A.U.
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
|
6-15 |
|
Trukhan D.I., Sulimov A.F., Trukhan L.Yu.
Diabetes mellitus and periodontal diseases: together or in parallel?
|
16-22 |
|
Sharonova L.A., Bulgakova S.V., Dolgikh Yu.A., Kosareva O.V., Merzlova P.Ya., Treneva E.V., Kurmaev D.P.
Extraosseous symptoms of primary hyperparathyroidism in the practice of a general practitioner
|
24-32 |
|
Tarasova A.A., Kostinov M.P., Novopoltseva E.G.
Vaccination against pneumococcal infection in patients with diabetes mellitus
|
33-39 |
|
|
Koteshkova O.M., Antsiferov M.B., Antsiferova D.M.
Current trends in self-monitoring of glycemic levels
|
40-48 |
ORIGINAL ARTICLES |
|
Elsukova O.S., Nikitina E.A.
Evaluation of non-glycemic effects of a fixed combination of alogliptin and pioglitazone
|
49-53 |
|
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Romashkina L.P., Golubeva Yu.V.
Efficacy and safety of the russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
|
54-61 |
|
Ignatenko G.A., Bagriy A.E., Mikhailichenko E.S., Prikolota A.V., Mogilevskaya K.E., Sabelnikova Ya.S., Belikov V.A.
Potentials for the use of azilsartan and spironolactone in patients with arterial hypertension and diabetes mellitus
|
62-70 |
|
Azizova K.V., Volkova A.R., Dora S.V., Zimina M.V., Ermoolinskaya T.S.
Features of folliculogenesis in women with different body mass index: a cross-sectional comparative study
|
72-77 |
|
Chernetsova A.S., Sharov M.N., Adamyan L.V., Murvatov K.D., Kiselev S.I., Prokofieva Yu.S., Goncharov I.N.
Determination of catecholamine levels in patients with chronic pelvic pain associated with endometriosis
|
78-83 |
|
Aramisova L.S., Zhurtova I.B., Akhkubekova Z.A.
Model for predicting the severity and outcome of COVID-19 in patients with diabetes mellitus and obesity, created based on artificial intelligence methods
|
84-90 |
|
Mozgunova V.S., Volkova A.R., Semikova G.V., Khalimov Yu.Sh., Vasilevsky D.I., Balandov S.G., Anisimova K.A.
Blood lipid profile in patients with obesity and type 2 diabetes mellitus and without type 2 diabetes mellitus before and after bariatric surgery
|
91-96 |
ALGORITHMS |
|
E.V. Biryukova
Diabetic neuropathy: diagnostic algorithm and approaches to treatment
|
97-99 |
|
|
Chernikova N.A., Prokhorova K.S., Gancho I.M.
Adherence to modern technologies of glycemic management in diabetic patients
|
100-105 |
|
Ladygina D.O., Soldatova V.D., Osipova E.V., Antsiferova E.O., Sotnikov D.N., Platonova N.M., Beltsevich D.G., Fadeev V.V.
Laboratory diagnostics of pheochromocytoma: a modern view on the problem
|
106-113 |
|
Elsukova O.S.
Possibilities of using insulin degludec in the treatment of diabetes mellitus in patients with previous ineffective insulin therapy: analysis of clinical cases
|
114-123 |
|
Kanavets N.S., Rebrova D.V.
Clinical cases of management of patients with type 2 diabetes mellitus using GLP-1 receptor agonists
|
124-132 |
|
Pankratova M.S., Ionitsy K.A., Raykina E.N.
Severe dyslipidemia as a result of hypopituitarism decompensation in a girl with a PROP1 gene defect: a case report
|
134-138 |
|
Smirnova E.Yu.
Efficacy of gosogliptin in the treatment of type 2 diabetes mellitus: a clinical case
|
140-145 |
|
Kudinova E.V., Davidenko I.Yu., Volkova N.I.
Variant of development of comorbid condition with late diagnosis of pancreatogenic diabetes mellitus: clinical case
|
146-149 |
MEDICAL MANAGEMENT |
|
Trukhanova I.G., Gureev A.D., Bibikova E.G., Lunina A.V.
The role of artificial neural networks and clinical decision support systems in healthcare information systems
|
150-156 |
Русский
